Replica Analytics

Replica Analytics is a Canadian technology company based in Ottawa, founded in 2019 or early 2020. The company specializes in AI-driven synthetic data generation for the healthcare and life sciences sectors. Its flagship product, the Replica Synthesis software platform, offers a comprehensive suite for generating synthetic data, ensuring privacy, and assessing re-identification risks. The platform's latest version, 3.0, was released in April 2023 and features an intuitive user interface.

The company provides synthetic data generation that uses machine learning to create privacy-safe datasets, supporting various applications such as clinical research and drug development. It also offers privacy assurance tools that help ensure compliance with regulations like HIPAA and GDPR. Replica Analytics serves a range of clients, including healthcare organizations, pharmaceutical companies, and clinical research organizations, and has partnered with notable entities like Merck Canada and the University of Alberta. In January 2022, Replica Analytics became a wholly owned subsidiary of Aetion, enhancing Aetion's Evidence Platform with synthetic data capabilities.